FindMyRecallSubscribe
Class I: serious health riskTerminated

Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy Tacrolimus Recall

Tacrolimus (Brand Capsules ) 0

Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy · Berkeley, CA

Risk level
Class I
Reported by FDA
Jun 15, 2022
Recall ID
D-1167-2022
Check your lot numberHow we source this data

Summary

Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy recalled Tacrolimus starting Apr 15, 2022. The FDA classified it as Class I (serious health risk) and published enforcement report D-1167-2022 on Jun 15, 2022. Reason: Subpotent drug. Status: Terminated.

Why it was recalled

Subpotent drug

Product description

Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704,

Lot numbers, UPCs & expiration codes

Lot #: 03312022@29, BUD: 6/10/2022

Where it was sold

CA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1167-2022
Classification
Class I
Status
Terminated
Recall initiated
Apr 15, 2022
FDA report date
Jun 15, 2022
Quantity
1,966 mLs in 12 oz; 2 oz; 16 oz and 6 oz bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy

Original FDA data

Every field from FDA enforcement report D-1167-2022, exactly as published.

Show all FDA fields
City
Berkeley
State
CA
Status
Terminated
Country
United States
Event ID
90289
Address
2461 Shattuck Ave
Code information
Lot #: 03312022@29, BUD: 6/10/2022
Postal code
94704
Report date
Jun 15, 2022
Product type
Drugs
Recall number
D-1167-2022
Classification
Class I
Recalling firm
Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy
Product quantity
1,966 mLs in 12 oz; 2 oz; 16 oz and 6 oz bottles
Termination date
Nov 7, 2022
Reason for recall
Subpotent drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704,
Distribution pattern
CA
Recall initiation date
Apr 15, 2022
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Jun 27, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1167-2022, published Jun 15, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls